Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,094 | -254,789 | -248,931 | -246,541 | -6,460 |
| Depreciation Amortization | 60,208 | 248,770 | 185,608 | 121,899 | 60,010 |
| Accounts receivable | 196,440 | -79,071 | 33,053 | -26,720 | 124,272 |
| Other Working Capital | 54,281 | -59,945 | 75,263 | 69,593 | 50,655 |
| Other Operating Activity | -161,123 | 210,135 | 43,399 | 76,591 | -108,134 |
| Operating Cash Flow | $139,712 | $65,100 | $88,392 | $-5,178 | $120,343 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,000 | N/A | 1,000 | N/A |
| PPE Investments | -11,399 | -48,795 | -36,329 | -19,797 | -12,681 |
| Net Acquisitions | N/A | -84,714 | N/A | -84,714 | -84,714 |
| Purchase Sale Intangibles | -338 | -41,800 | -126,514 | -10,000 | N/A |
| Other Investing Activity | -338 | -41,800 | -126,514 | -10,000 | 0 |
| Investing Cash Flow | $-11,737 | $-174,309 | $-162,843 | $-113,511 | $-97,395 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 85,000 | 85,000 | 85,000 | N/A |
| Debt Issued | 80,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | -72,659 | -123,272 | -107,281 | -63,010 | -9,796 |
| Common Stock Issued | N/A | 662 | 662 | 239 | 111 |
| Common Stock Repurchased | N/A | -1,722 | N/A | -1,722 | N/A |
| Other Financing Activity | -20,241 | -67,288 | -62,834 | -58,828 | -51,885 |
| Financing Cash Flow | $-12,900 | $-106,620 | $-84,453 | $-38,321 | $-61,570 |
| Exchange Rate Effect | 767 | -5,683 | -1,944 | -1,547 | -1,572 |
| Beginning Cash Position | 35,227 | 256,739 | 256,739 | 256,739 | 256,739 |
| End Cash Position | 151,069 | 35,227 | 95,891 | 98,182 | 216,545 |
| Net Cash Flow | $115,842 | $-221,512 | $-160,848 | $-158,557 | $-40,194 |
| Free Cash Flow | |||||
| Operating Cash Flow | 139,712 | 65,100 | 88,392 | -5,178 | 120,343 |
| Capital Expenditure | -11,399 | -48,795 | -37,329 | -19,797 | -12,681 |
| Free Cash Flow | 128,313 | 16,305 | 51,063 | -24,975 | 107,662 |